Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…6.6%) and bowel (AOR 1.38; 47.5% vs 35.4%) disorders.Conclusion Cholecystectomy is prevalent worldwide and varies across world regions. A histo…
…rion diseases near-perfectly and could act as a flag to suspect prion diseases.thomas.coysh@nhs.net…
… 0.89 – survey-cohort).Conclusion We demonstrate the utility of EQ-5D-5L to appraise HRQoL in the UK FSHD patients. EQ-5D-5L health util…
…nd 0.49 (95% CI 0.41 to 0.58) to 0.93 (95% CI 0.72 to 1.20) for SGLT2i. Prescriptions for both ARNi and SGLT2i showed a social gradien…
…(SLE), rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS)—in Brazil’s public and private healthcare systems from 201…
…and 2019 using primary care electronic healthcare records.Adult asthma patients with mental health disorders (exposed) were matched by…
…arched. All randomised controlled clinical trials investigating Finerenone combined with SGLT2i for DKD treatment will be included. Data e…
…mastobart, and no treatment-related deaths occurred.Conclusions Nelmastobart combined with capecitabine demonstrated a manageable safety pro…
…01 is a promising novel immunotherapy strategy to treat cancer. RIDE-001’s pharmacological activity translates across primary human immu…
… enhance tumor immunity/anti-tumor activities in animal models. HX111 could be such a candidate drug for tumor treatment, with enhanc…
… activation in vitro, consistent with preclinical evaluation of ivonescimab. 1 In xenograft models, CR-001 demonstrated potent anti-tumor a…